pharmaphorum
MAY 19, 2022
Moderna has joined forces with non-profit organisation IAVI on a third phase 1 trial of its candidate HIV vaccine in Africa, where the burden of the virus is still being keenly felt. IAVI (the International AIDS Vaccine Initiative) has started screening subjects to be included in the study, called IAVI G003, at centres in Rwanda and South Africa, said the biotech.
Outsourcing Pharma
MAY 18, 2022
An expert from the AI-focused technology company shares insights as to how it can be harnessed to better interpret, and even predict, patient behavior.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Times
MAY 17, 2022
Authorisation of the treatment is based on results from the phase 3 trial
The Luxe Pharmacist
MAY 19, 2022
I’m honored this post has been so highly requested by you all! My hair’s journey back to health has been a long one and I’m so proud of how far it has come. Please keep in mind my hair has recovered over many years and while many things can help damaged hair it may still take a long time to fully recover. The key is to stop further damage from occurring and make sure your new growth stays happy and healthy.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
MAY 18, 2022
FDA veteran Bakul Patel has joined Google as its new senior director of global digital health strategy, ending a stint at the regulator that lasted more than 13 years. Bakul Patel. Patel – who is currently director for digital health at the FDA – said on social media that he is “looking forward to learning from the teams in health across Google and Alphabet and helping build a unified digital health and regulatory strategy.” He was also involved in the creation of the FDA’s Dig
Outsourcing Pharma
MAY 18, 2022
A leader from the neurobiomarker platform provider tells how use of ML and other advanced analytical tools can help make better use of complex information.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
The Happy PharmD
MAY 19, 2022
By going through pharmacy school, you have a well-rounded background in various areas, including communication skills through delivering presentations and counseling patients, motivational interviewing experience, and some degree of technical writing experience. The curriculum is structured to make the average pharmacist an excellent communicator, a fast learner, and flexible enough to fit into different fields.
pharmaphorum
MAY 19, 2022
An observational study in the UK has found evidence that COVID-19 vaccination can help alleviate the lingering symptoms that afflict some people who contract the virus, often referred to as ‘long COVID’ There have been persistent anecdotal reports that vaccines can help people with persistent symptoms get better, but the study published in the British Medical Journal is the first to explore the connection in large numbers of patients.
Outsourcing Pharma
MAY 20, 2022
The National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health, has awarded a total of $577m to establish nine Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern.
Pharma Mirror
MAY 17, 2022
California, Crown Bioscience and Medical & Biological Laboratories (MBL), JSR Life Sciences companies, today announced the formation of a joint venture, to further expand the provision of Crown Bioscience’s preclinical services to Japanese customers. The new entity named “Crown Bioscience & MBL”, is a long-term strategic partnership that is expected to accelerate growth for both companies.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The Happy PharmD
MAY 16, 2022
We have all been at various points in our lives where we felt we have had enough and desired a change. It could be breaking free from an addiction, deciding to start a family, or in this case leaving a job where you have been unhappy and stressed. However, a few days or weeks down the line, we end up not following our action plan or even fail to draft out one.
pharmaphorum
MAY 20, 2022
After a non-committal appraisal of Big Health’s Sleepio app for insomnia last November in draft guidance from NICE, the cost-effectiveness agency has come out in favour of the digital therapy. The earlier draft guidance showed that NICE was uncertain whether Sleepio would save money for the NHS, but its latest document recommends the app as a cost-saving option for treating insomnia in primary care “for people who would otherwise be offered advice about sleep hygiene or sleeping pill
Outsourcing Pharma
MAY 19, 2022
Experts and organizations are honoring the occasion (designed to celebrate research accomplishments and achievements) with insights, education, and more.
Board Vitals - Pharmacist
MAY 15, 2022
Cardiologists are required to complete recertification as part of their requirements to remain a practicing physician. The Cardiovascular Disease Maintenance of Certification Exam can be difficult, with a pass rate in 2021 of 88%. What are some things you need to know before you sit for the exam? Here are some common questions surrounding the Cardiology MOC Exam: When is the Cardiology MOC exam offered?
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
The Spirit Pharmacist
MAY 15, 2022
Pharmacology and Drug Interactions of 5-MeO-DMT. Mystery and 5-MeO-DMT. One compound I seem to get more questions about than others is 5-MeO-DMT. It makes sense given there is very little data available, a few cases of death reported involving use, and may be the most reliable in occasioning mystical or transformative types of experiences. In short, it's a substance that appears to have a lot of potential for both benefit or harm due to its incredibly powerful effects. 5-MeO-DMT: A Molecule on t
pharmaphorum
MAY 16, 2022
Adele Waugaman, senior digital health coordinator of the COVID-19 response at the United States Agency for International Development (USAID), tells us what the agency focuses on to strengthen digital health infrastructure globally and improve and expand healthcare access. USAID learned a great deal from the Ebola outbreak in West Africa concerning effective digital health distribution and strategies for digital health implementation that were then applied to its COVID-19 response globally – alth
Outsourcing Pharma
MAY 18, 2022
The pharmaceutical company is partnering with Yseop to install the software companyâs Augmented Analyst, designed to elevate and accelerate data analysis.
Colors Make me Happy
MAY 14, 2022
MUSC College of Pharmacy Graduation 2022 Good afternoon! Dear Faculty, families, loved ones, and GRADUATES. Thank you for inviting me to join you on this very important milestone in your life. You did it and I am proud of YOU! Congratulations. Dean Hall asked me to share with you my pharmacy journey. Instead, I would like to talk to you about the life journey of a seven-year-old refugee girl.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Times
MAY 20, 2022
Scientists demonstrated that AZD1236 halts oedema while reducing spinal cord breakdown at site of injury
pharmaphorum
MAY 16, 2022
Blood sugar control drug Mounjaro has been granted US regulatory approval, giving type 2 diabetics another way to help keep their glucose levels in check. Eli Lilly’s Mounjaro (tirzepatide) was given the green light by the US Food and Drug Administration after the glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 glucagon-like peptide-1 (GLP-1 ) receptor agonist showed its effectiveness when used in conjunction with diet and exercise.
Outsourcing Pharma
MAY 18, 2022
The digital therapeutics specialist has announced the last patient has ended participation in a study investigating a precision solution for hypertension.
Med Ed 101
MAY 15, 2022
Chlorthalidone and hydrochlorothiazide (podcast) are both thiazide diuretics. They are primarily used in the management of hypertension and occasionally for the management of edema. Hypokalemia, frequent urination, and risk for dehydration are all common adverse effects of both of these agents. The drug interaction profiles’ (like this one with lithium) are very similar as well. […].
Pharma Times
MAY 18, 2022
Device delivers currents to the brain to restore activity usually lowered in depression patients
pharmaphorum
MAY 20, 2022
Several of the top pharmaceutical companies have joined a new coalition that aims to improve access to cancer medicines in low- and lower-middle-income countries (LLMICs). The new initiative – called ATOM (Access to Oncology Medicines) – pledges to tackle the issue that fewer than 50% of the cancer medicines on the World Health Organization’s essential medicines list are available in developing nations around the world.
Outsourcing Pharma
MAY 16, 2022
The companyâs analysis of 2.5m patients worldwide suggest a growing proportion of younger patients, with implications for future study design and deployment.
Pharma Manufacturing
MAY 20, 2022
Supply chain challenges and industry trends are spurring new business strategies
Pharma Times
MAY 19, 2022
Gifford is supporting the launch with a philanthropic donation of £14.
pharmaphorum
MAY 16, 2022
A digital health startup accelerator is launching in Italy, with more than €6 million backing the new enterprise. Called VITA, the accelerator will support up to 10 startups focused on digital transformation of the health system. The project is backed by asset management company CDP Venture Capital SGR, with help from digital health consultancy Healthware Group (pharmaphorum’s parent company) and Danish accelerator Accelerace.
Outsourcing Pharma
MAY 19, 2022
This monthâs announcements on new technology, awards, partnerships, and more include eClinical Solutions, COTA, Greenphire, and other notable companies.
Med Ed 101
MAY 18, 2022
Nicotine patches are a useful tool in the management of smoking cessation. The success and tolerability of this form of nicotine replacement does require some pharmacology knowledge. I lay out my most important nicotine patch clinical pearls below. Nicotine Patch Clinical Pearls – Dosing Let’s start with the dosing of nicotine patches. A clinician must […].
Pharma Times
MAY 17, 2022
Team at Imperial College London will expand MELODY study to include immunosuppressed young people
pharmaphorum
MAY 20, 2022
UK scientists are being denied from joining the €95 billion Horizon research funding programme as a dispute over the trade border in Northern Ireland gets increasingly acrimonious. The UK’s involvement in the Horizon Europe programme as an associate member was included in the Brexit ‘divorce’ deal with EU, but has not been finalised.
Outsourcing Pharma
MAY 17, 2022
The pharmaceutical company reportedly opted to implement the cloud software provider's clinical trial management system to help streamline its processes.
Expert insights. Personalized for you.
145 
Let's personalize your content